Prenatal ultrasonographic detection and prenatal (prior to birth) management of hereditary retinoblastoma

Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):861-862. doi: 10.1007/s00417-017-3841-4. Epub 2017 Nov 19.

Authors

Christina Stathopoulos^{1

2}, Emil Anthony T Say¹, Carol L Shields³

Affiliations

¹ Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, 14th floor, Philadelphia, PA, 19107, USA.
² Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Lausanne, Switzerland.
³ Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, 14th floor, Philadelphia, PA, 19107, USA. carolshields@gmail.com.

PMID: 29151167
DOI: 10.1007/s00417-017-3841-4

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents / therapeutic use*
Disease Management*
Eye Neoplasms / diagnosis*
Eye Neoplasms / drug therapy
Eye Neoplasms / embryology
Female
Humans
Pregnancy
Pregnancy Complications, Neoplastic*
Retina / embryology
Retina / growth & development*
Retinoblastoma / diagnosis*
Retinoblastoma / drug therapy
Retinoblastoma / embryology
Ultrasonography, Prenatal / methods*

Substances

Antineoplastic Agents